“…The marker was not expressed by congenital non-progressive hemangiomas, vascular and lymphatic malformations, reactive granulation tissue, oral varix, pyogenic granulomas, epithelioid hemangiomas, or hemangioendotheliomas. 3 , 16 , 17 , 20 , 21 , 23 Our case is in agreement with a study done by Johann et al, 20 which concluded that GLUT1 could be used an auxiliary marker for oral benign vascular lesions.…”